1 In 4 Biotech Drugs Gets Safety Warning: Study
About one-quarter of biotechnology drugs approved in the the U.S. and European Union have been subject to safety-related regulatory actions within their first decade on the market, a new study has...To view the full article, register now.
Already a subscriber? Click here to view full article